Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 for Body Recomp Stack Research: Protocol Comparison

The table below compares three common CJC-1295 research stacking approaches, detailing target outcomes, typical adjunct compounds, and realistic timelines for observable body composition changes. Pure CJC-1295 Monotherapy GHRH receptor agonism → sustained GH/I

This comparison does not assign a generated winner or score.

  • The table below compares three common CJC-1295 research stacking approaches, detailing target outcomes, typical adjunct compounds, and realistic timelines for observable body composition changes.
  • Pure CJC-1295 Monotherapy
  • GHRH receptor agonism → sustained GH/IGF-1 elevation
  • None (peptide-only baseline)
  • 8–12 weeks for measurable recomp
  • Best for isolating CJC-1295 effects; slower than stacked protocols but clearer attribution
  • CJC-1295 + Ghrelin Mimetic
  • Dual-pathway GH stimulation (GHRH + ghrelin receptors)
  • MK-677 or GHRP-6
  • 6–10 weeks for lean mass gain + fat loss
  • Synergistic GH pulse amplitude; higher appetite may complicate deficit adherence
  • CJC-1295 + Caloric Cycling
  • GH elevation during refeed phases to preserve muscle
  • Structured refeeds 1–2x/week
  • 10–16 weeks for significant recomp
  • Ideal for advanced subjects; requires precise macronutrient tracking and training periodisation
More references

Related material